SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $572,100 | -74.1% | 15,000 | -78.1% | 0.08% | -68.1% |
| Q2 2022 | $2,213,000 | +57.3% | 68,500 | +61.2% | 0.26% | +550.0% |
| Q1 2022 | $1,407,000 | -84.1% | 42,500 | -79.6% | 0.04% | -77.9% |
| Q4 2021 | $8,870,000 | +39.5% | 208,500 | +45.3% | 0.18% | -6.2% |
| Q3 2021 | $6,358,000 | -2.6% | 143,500 | +24.9% | 0.19% | -16.8% |
| Q2 2021 | $6,527,000 | -62.0% | 114,900 | -49.9% | 0.23% | -45.9% |
| Q1 2021 | $17,155,000 | +5877.4% | 229,200 | +7540.0% | 0.43% | +479.7% |
| Q4 2018 | $287,000 | – | 3,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |